This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

HIV Diagnostics Market

Market Insights on HIV Diagnostics covering sales outlook, demand forecast & up-to-date key trends

HIV Diagnostics Market by Product, Test Type, End User & Region - Forecast 2022 - 2032

HIV Diagnostics Market Outlook (2022-2032)

[306 Pages Report] The HIV diagnostics market is anticipated to record a steady CAGR of 7.9% during the period 2022-2032.

During the forecast period, the HIV diagnostics market is predicted to rise from US$ 3.0 Bn in 2022 to US$ 6.4 Bn in 2032.

“Favorable regulatory environment and substantial investment in R&D activities by market participants for the development of improved quality HIV testing kits for home use is likely to propel the HIV diagnostics market growth.”

The demand for HIV diagnostics is forecasted to grow due to factors such as the rising global prevalence of HIV/AIDS, as well as the rising number of blood transfusions and blood donations.

Attributes

Details

HIV Diagnostics Market CAGR (2022-2032)

7.9%

HIV Diagnostics Market Value (2022)

US$ 3.0 Bn

HIV Diagnostics Market Value (2032)

US$ 6.4 Bn

What is the COVID-19 Impact on the HIV Diagnostics Market?

The COVID-19 outbreak had a negative impact on the HIV diagnostics market share. To combat community transmission of the COVID-19 virus, many parts of the world implemented preventive lockdown. As a result, the sales of HIV diagnostic procedures and patient visits in healthcare institutions have decreased significantly, severely impacting HIV diagnostics market growth.

A disruption in ART supply and preventive measures, according to a modelling exercise conducted by the WHO and UNAIDS for Sub-Saharan Africa, might increase HIV-related mortality and new infections across the region. Due to this factor the demand for HIV diagnostics increased.

As a precaution, countries were asked to establish a strategy for maintaining HIV prevention and treatment services throughout the COVID-19 pandemic. Unless immediate action was taken to ensure a continuous supply of pharmaceuticals and access to preventative treatments, the nations' gains would be lost.

The demand for HIV diagnostics grew significantly in 2021 as the number of COVID-19 patients decreased. The sales of HIV diagnostic procedures in settings with lower risk of infection have increased as a result of healthcare facilities establishing standard operating practices and a lower death rate linked to COVID-19.

As a result of the shrinking COVID 19 patient population, the sales of HIV diagnostic procedures and overall market share are likely to increase significantly in the near future.

Customize this Report

Let us know your requirement to get
100% FREE customization

What is the Key Dynamics Governing the Growth of the HIV Diagnostics Market?

The demand for HIV diagnostics is growing as it detects the presence of the human immunodeficiency virus (HIV), which causes acquired immunodeficiency syndrome. HIV diagnostics is accomplished by performing tests on serum, saliva, or urine samples.

The sales of HIV diagnostic procedures are anticipated to grow as these techniques aid in detecting antibodies, antigens, and RNA. Furthermore, the demand for HIV diagnostics is growing as people become more aware of HIV, the test's secrecy, and appropriate counselling. Due to these factors, the HIV diagnostics market is projected to grow rapidly.

The demand for HIV diagnostics tests is anticipated to grow as they are critical in the accurate diagnosis and management of a person's health. The HIV diagnostics market share is projected to rise as more HIV diagnostics tests become available around the world.

However, the high costs of Nucleic Acid Testing (NAT) and the lack of NAT mandates in underdeveloped nations are limiting the growth of HIV diagnostics market's expansion.

The demand for HIV diagnostics is projected to rise as they provide simple quick assays with visual testing, as well as easy-to-handle home sample collecting approaches that may be utilized by health care personnel and customers at home. These factors are responsible for boosting the sales of HIV diagnostic procedures and have paved the way for the HIV diagnostics market to grow.

Furthermore, the sales of HIV diagnostic procedures are anticipated to grow due to the benefits provided by point-of-care tools and kits and increased government initiatives.

Rapid HIV tests are often known as point-of-care (PoC) HIV tests. HIV diagnosis often entails pre-test counselling, HIV testing, and post-test counselling, with patients expected to return for test results at a later date.

While the patient is still in the lab for PoC HIV diagnosis, counselling and screening are done simultaneously. If necessary, confirmation tests are performed. Individuals are not obliged to return for their results because pre-test and post-test counselling are done at the same time in PoC testing, making it a very convenient alternative.

As a result of this, the demand for HIV diagnostics is projected to rise at a significant pace during the forecast period.

The sales of HIV diagnostics procedures are projected to rise as rapid HIV testing yields results in about 30 minutes, removing the stress of waiting for results. Undiagnosed HIV cases and those who have not returned for follow-up testing are the major reasons for rapid HIV testing.

The demand for HIV diagnostics improved PoC kits and equipment is increasing as a consequence of its multiple benefits, which is projected to aid in the growth of the HIV diagnostics market size in the coming years.

Comparative View of Adjacent HIV Diagnostics Market

HIV Diagnostics Market:

Attributes

HIV Diagnostics Market

CAGR (2022 - 2032)

7.9%

Market Value (2026)

US$ 4.07 Bn

Growth Factor

Rising global prevalence of HIV/AIDS, as well as the rising number of blood transfusions and blood donations.

Opportunity

Due to multiple advantages, the demand for technologically advanced PoC kits and instruments is on the rise

Key Trends

Key players' substantial investment in R&D efforts for the development of improved quality HIV testing kits for home use.

STD Diagnostics Market:

Attributes

STD Diagnostics Market

CAGR (2022 - 2032)

4.8%

Market Value (2026)

US$ 121.09 Bn

Growth Factor

Increased public awareness and patient education to drive the market growth.

Opportunity

Countries around the world are focused on implementing nationwide screening tests to boost STD diagnosis coverage.

Key Trends

The change from conventional methods to molecular diagnostics for the detection of STDs.

Point of Care Testing Market:

Attributes

Point of Care Testing Market

CAGR (2022 - 2032)

7.4%

Market Value (2026)

US$ 44.51 Bn

Growth Factor

POCT services have grown in popularity as the prevalence of chronic diseases and acute infections has increased around the world.

Opportunity

The demand for point of care tests for rapid diagnosis is growing due to their convenience of use, cost-effectiveness, and small product size.

Key Trends

POCT compliance, safety, and usability have become increasingly important as the scope of use and penetration in developing economies has grown.

According to Centers for Disease Control and Prevention (CDC), people aged 13 to 64 should be tested for HIV at least once as part of a routine health check. As a result of this, the HIV diagnostics

The demand for HIV diagnostics is rising as HIV infection remains a major public health concern around the world. As a result, the sales of HIV diagnostic procedures are also predicted to rise as HIV diagnosis has become increasingly vital in order to prevent the disease from spreading further.

The global HIV diagnostics market is booming due to rising demand for rapid testing and point-of-care (PoC) HIV tests around the world. In addition, people's disposable income is increasing, which is encouraging HIV diagnostics market growth.

Additionally, expanding government and private sector awareness campaigns regarding HIV diagnostics and testing processes, as well as the growing presence of various industry players in this region, is projected to have a beneficial impact on the demand for HIV diagnostics. Furthermore, the increasing use of point-of-care testing in numerous nations is likely to propel African countries to use HIV diagnostic tests.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

What is the Segmentation Outlook for the HIV Diagnostics Market?

The consumable sector accounted for the largest market share in the global HIV diagnosis market. Consumption of consumables such as assays, reagents, and kits are on the rise, which is propelling the HIV diagnostics market forward.

Which Segment is likely to Lead the HIV Diagnostics Market by End User?

The hospitals sector is expected to lead the HIV diagnostics market, by end use, and grow at a CAGR of 7.2% over the projected period. Continuous technical developments in laboratory devices are likely to support segment expansion by improving testing outcomes.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Which Segment is likely to Lead the HIV Diagnostics Market by Test Type?

With a CAGR of 7.0% the body tests are predicted to account for the biggest proportion of the market by test type. This substantial percentage can be ascribed to advances in HIV diagnosis technology, increased HIV awareness, and increased blood donations.

What is the Regional Analysis for the HIV Diagnostics Market?

Regions

CAGR (2022-2032)

US Market 

7.4%

UK Market

6.7%

China Market

7.2%

Japan Market

6.2%

South Korea Market

5.5%

Due to rising product approval in the area, North America is predicted to dominate the global HIV diagnostics market. The US Food and Treatment Administration (FDA) granted Vela Diagnostics de novo approval for its Sentosa SQ HIV-1 Genotyping Assay, which was created to detect HIV-1 genomic drug resistance mutations (DRMs).

Furthermore, Abbott Laboratories gained WHO Prequalification approval (WHO PQ) for m-PIMA HIV-1/2 VL, the first point-of-care viral load diagnostic test, in May 2019. The portable molecular point-of-care test is intended for use in resource-constrained environments. The product's prequalification status makes it eligible for purchase by United Nations organizations.

According to the European Centre for Disease Prevention and Control (ECDC) study from 2017, over 51 percent of all HIV cases in Europe were detected late in 2015, and around 28 percent had progressed HIV infection. Furthermore, in nine European nations, including Austria, Estonia, Greece, Italy, Latvia, Lithuania, Romania, Slovenia, and Sweden, the rate of late diagnoses was greater than 50%.

In 2021, the African HIV diagnostics market accounted for approximately 38% of the global market, and it is expected to continue to rise rapidly over the analyzed period. High rates of HIV infections in African countries due to rising rates of teenage pregnancy, and a lack of quality sex education are some of the primary drivers of regional HIV diagnostics market expansion.

The HIV diagnostics market is likely to be driven by rising knowledge of available HIV aids treatment options and cost-effective HIV medication therapy. However, the quick replacement of HIV-AIDS treatments and therapies by new drugs and therapies, as well as patient protection losses, are limiting the worldwide HIV diagnostics market's growth.

The growth of the HIV diagnostics market in Asia is likely to be led by developing countries such as India and China, which have growing demographics and economies. Furthermore, the global HIV diagnostics market is likely to benefit from increased knowledge about HIV-AIDS treatment and technological advancements in HIV-AIDS testing.

How is the Competition in the HIV Diagnostics Market?

There are a few major competitors in the HIV diagnostics market. To stay competitive in the HIV diagnostics market, these companies are using a variety of growth tactics such as collaboration, acquisition & merger, partnership, and new launches.

Recent Developments in the HIV Diagnostics Market

  • Atomo Diagnostic and PrEP Health Pty Ltd struck a distribution deal for HIV self-tests in December 2020. This has expanded the customer base and boosted the HIV testing product line.
  • Hologic Inc. gained FDA approval for its HIV-1 viral load monitoring test in November 2020. This has aided the company in expanding its HIV diagnostics product portfolio.
  • OraSure Technologies, Inc. purchased UrSure, Inc., a leading laboratory testing company, in May 2020. The company's HIV diagnostics product offerings have been strengthened as a result of this acquisition.

Key Players

Key Segments

By Product:

  • Consumables
  • Instruments
  • Software & Services

By Test Type:

  • Antibody Tests
  • Viral Load Tests
  • CD4 Tests
  • Others

By End User:

  • Diagnostic Laboratories
  • Hospitals
  • Others

By Region:

  • North America
  • Europe
  • Asia Pacific
  • Middle East and Africa
  • Latin America

Frequently Asked Questions

The HIV diagnostics market is projected to register a CAGR of 7.9% during the period 2022-2032.

North America is predicted to dominate the global HIV diagnostics market.

The hospitals sector is expected to lead the HIV diagnostics market by end use.

The HIV diagnostics market is anticipated to grow from US$ 3.0 Bn in 2022 to US$ 6.4 Bn by 2032.

Asia Pacific (APAC) region has the highest growth potential in the HIV diagnostics market.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Summary of Statistics

    1.3. Key Market Characteristics & Attributes

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Risks and Trends Assessment

    3.1. Risk Assessment

        3.1.1. COVID-19 Crisis and Impact on HIV Diagnostics

        3.1.2. COVID-19 Impact Benchmark with Previous Crisis

        3.1.3. Impact on Market Value (US$ Mn)

        3.1.4. Assessment by Key Countries

        3.1.5. Assessment by Key Market Segments

        3.1.6. Action Points and Recommendation for Suppliers

    3.2. Key Trends Impacting the Market

    3.3. Formulation and Product Development Trends

4. Market Background

    4.1. HIV Diagnostics Market, by Key Countries

    4.2. HIV Diagnostics Market Opportunity Assessment (US$ Mn)

        4.2.1. Total Available Market

        4.2.2. Serviceable Addressable Market

        4.2.3. Serviceable Obtainable Market

    4.3. Market Scenario Forecast

        4.3.1. Demand in optimistic Scenario

        4.3.2. Demand in Likely Scenario

        4.3.3. Demand in Conservative Scenario

    4.4. Investment Feasibility Analysis

        4.4.1. Investment in Established Markets

            4.4.1.1. In Short Term

            4.4.1.2. In Long Term

        4.4.2. Investment in Emerging Markets

            4.4.2.1. In Short Term

            4.4.2.2. In Long Term

    4.5. Forecast Factors - Relevance & Impact

        4.5.1. Top Companies Historical Growth

        4.5.2. Growth in Automation, By Country

        4.5.3. Patch Management Adoption Rate, By Country

    4.6. Market Dynamics

        4.6.1. Market Driving Factors and Impact Assessment

        4.6.2. Prominent Market Challenges and Impact Assessment

        4.6.3. HIV Diagnostics Market Opportunities

        4.6.4. Prominent Trends in the Global Market & Their Impact Assessment

5. Key Success Factors

    5.1. Manufacturers’ Focus on Low Penetration High Growth Markets

    5.2. Banking on with Segments High Incremental Opportunity

    5.3. Peer Benchmarking

6. Global HIV Diagnostics Market Demand Analysis 2015-2021 and Forecast, 2022-2032

    6.1. Historical Market Analysis, 2015-2021

    6.2. Current and Future Market Projections, 2022-2032

    6.3. Y-o-Y Growth Trend Analysis

7. Global HIV Diagnostics Market Value Analysis 2015-2021 and Forecast, 2022-2032

    7.1. Historical Market Value (US$ Mn) Analysis, 2015-2021

    7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032

        7.2.1. Y-o-Y Growth Trend Analysis

        7.2.2. Absolute $ Opportunity Analysis

8. Global HIV Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032, By Product

    8.1. Introduction / Key Findings

    8.2. Historical Market Size (US$ Mn) Analysis By Product , 2015-2021

    8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product , 2022-2032

        8.3.1. Consumables

        8.3.2. Instruments

        8.3.3. Software & Services

    8.4. Market Attractiveness Analysis By Product

9. Global HIV Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032, By Test Type

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ Mn) Analysis By Test Type, 2015-2021

    9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Test Type, 2022-2032

        9.3.1. Antibody Tests

        9.3.2. Viral Load Tests

        9.3.3. CD4 Tests

        9.3.4. Others

    9.4. Market Attractiveness Analysis By Test Type

10. Global HIV Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032, By End User

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Mn) Analysis By End User , 2015-2021

    10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User , 2022-2032

        10.3.1. Diagnostic Laboratories

        10.3.2. Hospitals

        10.3.3. Others

    10.4. Market Attractiveness Analysis By End User

11. Global HIV Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032, By Region

    11.1. Introduction

    11.2. Historical Market Size (US$ Mn) Analysis By Region, 2015-2021

    11.3. Current Market Size (US$ Mn) & Analysis and Forecast By Region, 2022-2032

        11.3.1. North America

        11.3.2. Latin America

        11.3.3. Europe

        11.3.4. Asia Pacific

        11.3.5. Middle East and Africa (MEA)

    11.4. Market Attractiveness Analysis By Region

12. North America HIV Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032

    12.1. Introduction

    12.2. Pricing Analysis

    12.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    12.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        12.4.1. By Country

            12.4.1.1. U.S.

            12.4.1.2. Canada

            12.4.1.3. Rest of North America

        12.4.2. By Product

        12.4.3. By End User

        12.4.4. By Test Type

    12.5. Market Attractiveness Analysis

        12.5.1. By Country

        12.5.2. By Product

        12.5.3. By End User

        12.5.4. By Test Type

13. Latin America HIV Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032

    13.1. Introduction

    13.2. Pricing Analysis

    13.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    13.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        13.4.1. By Country

            13.4.1.1. Brazil

            13.4.1.2. Mexico

            13.4.1.3. Rest of Latin America

        13.4.2. By Product

        13.4.3. By End User

        13.4.4. By Test Type

    13.5. Market Attractiveness Analysis

        13.5.1. By Country

        13.5.2. By Product

        13.5.3. By End User

        13.5.4. By Test Type

14. Europe HIV Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032

    14.1. Introduction

    14.2. Pricing Analysis

    14.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    14.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        14.4.1. By Country

            14.4.1.1. Germany

            14.4.1.2. France

            14.4.1.3. U.K.

            14.4.1.4. Italy

            14.4.1.5. Benelux

            14.4.1.6. Nordic Countries

            14.4.1.7. Rest of Europe

        14.4.2. By Product

        14.4.3. By End User

        14.4.4. By Test Type

    14.5. Market Attractiveness Analysis

        14.5.1. By Country

        14.5.2. By Product

        14.5.3. By End User

        14.5.4. By Test Type

15. Asia Pacific HIV Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032

    15.1. Introduction

    15.2. Pricing Analysis

    15.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    15.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        15.4.1. By Country

            15.4.1.1. China

            15.4.1.2. Japan

            15.4.1.3. South Korea

            15.4.1.4. Rest of Asia Pacific

        15.4.2. By Product

        15.4.3. By End User

        15.4.4. By Test Type

    15.5. Market Attractiveness Analysis

        15.5.1. By Country

        15.5.2. By Product

        15.5.3. By End User

        15.5.4. By Test Type

16. Middle East and Africa HIV Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032

    16.1. Introduction

    16.2. Pricing Analysis

    16.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    16.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        16.4.1. By Country

            16.4.1.1. GCC Countries

            16.4.1.2. South Africa

            16.4.1.3. Turkey

            16.4.1.4. Rest of Middle East and Africa

        16.4.2. By Product

        16.4.3. By End User

        16.4.4. By Test Type

    16.5. Market Attractiveness Analysis

        16.5.1. By Country

        16.5.2. By Product

        16.5.3. By End User

        16.5.4. By Test Type

17. Key Countries HIV Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032

    17.1. Introduction

        17.1.1. Market Value Proportion Analysis, By Key Countries

        17.1.2. Global Vs. Country Growth Comparison

    17.2. US HIV Diagnostics Market Analysis

        17.2.1. Value Proportion Analysis by Market Taxonomy

        17.2.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.2.2.1. By Product

            17.2.2.2. By End User

            17.2.2.3. By Test Type

    17.3. Canada HIV Diagnostics Market Analysis

        17.3.1. Value Proportion Analysis by Market Taxonomy

        17.3.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.3.2.1. By Product

            17.3.2.2. By End User

            17.3.2.3. By Test Type

    17.4. Mexico HIV Diagnostics Market Analysis

        17.4.1. Value Proportion Analysis by Market Taxonomy

        17.4.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.4.2.1. By Product

            17.4.2.2. By End User

            17.4.2.3. By Test Type

    17.5. Brazil HIV Diagnostics Market Analysis

        17.5.1. Value Proportion Analysis by Market Taxonomy

        17.5.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.5.2.1. By Product

            17.5.2.2. By End User

            17.5.2.3. By Test Type

    17.6. Germany HIV Diagnostics Market Analysis

        17.6.1. Value Proportion Analysis by Market Taxonomy

        17.6.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.6.2.1. By Product

            17.6.2.2. By End User

            17.6.2.3. By Test Type

    17.7. France HIV Diagnostics Market Analysis

        17.7.1. Value Proportion Analysis by Market Taxonomy

        17.7.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.7.2.1. By Product

            17.7.2.2. By End User

            17.7.2.3. By Test Type

    17.8. Italy HIV Diagnostics Market Analysis

        17.8.1. Value Proportion Analysis by Market Taxonomy

        17.8.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.8.2.1. By Product

            17.8.2.2. By End User

            17.8.2.3. By Test Type

    17.9. BENELUX HIV Diagnostics Market Analysis

        17.9.1. Value Proportion Analysis by Market Taxonomy

        17.9.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.9.2.1. By Product

            17.9.2.2. By End User

            17.9.2.3. By Test Type

    17.10. UK HIV Diagnostics Market Analysis

        17.10.1. Value Proportion Analysis by Market Taxonomy

        17.10.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.10.2.1. By Product

            17.10.2.2. By End User

            17.10.2.3. By Test Type

    17.11. Nordic Countries HIV Diagnostics Market Analysis

        17.11.1. Value Proportion Analysis by Market Taxonomy

        17.11.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.11.2.1. By Product

            17.11.2.2. By End User

            17.11.2.3. By Test Type

    17.12. China HIV Diagnostics Market Analysis

        17.12.1. Value Proportion Analysis by Market Taxonomy

        17.12.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.12.2.1. By Product

            17.12.2.2. By End User

            17.12.2.3. By Test Type

    17.13. Japan HIV Diagnostics Market Analysis

        17.13.1. Value Proportion Analysis by Market Taxonomy

        17.13.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.13.2.1. By Product

            17.13.2.2. By End User

            17.13.2.3. By Test Type

    17.14. South Korea HIV Diagnostics Market Analysis

        17.14.1. Value Proportion Analysis by Market Taxonomy

        17.14.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.14.2.1. By Product

            17.14.2.2. By End User

            17.14.2.3. By Test Type

    17.15. GCC Countries HIV Diagnostics Market Analysis

        17.15.1. Value Proportion Analysis by Market Taxonomy

        17.15.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.15.2.1. By Product

            17.15.2.2. By End User

            17.15.2.3. By Test Type

    17.16. South Africa HIV Diagnostics Market Analysis

        17.16.1. Value Proportion Analysis by Market Taxonomy

        17.16.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.16.2.1. By Product

            17.16.2.2. By End User

            17.16.2.3. By Test Type

    17.17. Turkey HIV Diagnostics Market Analysis

        17.17.1. Value Proportion Analysis by Market Taxonomy

        17.17.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.17.2.1. By Product

            17.17.2.2. By End User

            17.17.2.3. By Test Type

        17.17.3. Competition Landscape and Player Concentration in the Country

18. Market Structure Analysis

    18.1. Market Analysis by Tier of Companies

    18.2. Market Concentration

    18.3. Market Share Analysis of Top Players

    18.4. Market Presence Analysis

        18.4.1. By Regional footprint of Players

        18.4.2. Product footprint by Players

19. Competition Analysis

    19.1. Competition Dashboard

    19.2. Competition Benchmarking

    19.3. Competition Deep Dive

        19.3.1. Siemens Healthineers

            19.3.1.1. Overview

            19.3.1.2. Product Portfolio

            19.3.1.3. Sales Footprint

            19.3.1.4. Strategy Overview

        19.3.2. F. Hoffmann-La Roche Ltd

            19.3.2.1. Overview

            19.3.2.2. Product Portfolio

            19.3.2.3. Sales Footprint

            19.3.2.4. Strategy Overview

        19.3.3. Abbott Laboratories

            19.3.3.1. Overview

            19.3.3.2. Product Portfolio

            19.3.3.3. Sales Footprint

            19.3.3.4. Strategy Overview

        19.3.4. Danaher Corporation

            19.3.4.1. Overview

            19.3.4.2. Product Portfolio

            19.3.4.3. Sales Footprint

            19.3.4.4. Strategy Overview

        19.3.5. Thermo-Fisher Scientific Inc

            19.3.5.1. Overview

            19.3.5.2. Product Portfolio

            19.3.5.3. Sales Footprint

            19.3.5.4. Strategy Overview

        19.3.6. Merck KGaA

            19.3.6.1. Overview

            19.3.6.2. Product Portfolio

            19.3.6.3. Sales Footprint

            19.3.6.4. Strategy Overview

        19.3.7. Becton, Dickinson & Company

            19.3.7.1. Overview

            19.3.7.2. Product Portfolio

            19.3.7.3. Sales Footprint

            19.3.7.4. Strategy Overview

        19.3.8. Hologic Inc

            19.3.8.1. Overview

            19.3.8.2. Product Portfolio

            19.3.8.3. Sales Footprint

            19.3.8.4. Strategy Overview

        19.3.9. Bio-Rad Laboratories

            19.3.9.1. Overview

            19.3.9.2. Product Portfolio

            19.3.9.3. Sales Footprint

            19.3.9.4. Strategy Overview

        19.3.10. Alere Inc

            19.3.10.1. Overview

            19.3.10.2. Product Portfolio

            19.3.10.3. Sales Footprint

            19.3.10.4. Strategy Overview

20. Assumptions and Acronyms Used

21. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 1: Global HIV Diagnostics Market Value (US$ Mn), By Product , 2015 – 2021

Table 2: Global HIV Diagnostics Market Value (US$ Mn), By Product , 2022 – 2032

Table 3: Global HIV Diagnostics Market Value (US$ Mn), By End User , 2015 – 2021

Table 4: Global HIV Diagnostics Market Value (US$ Mn), By End User , 2022 – 2032

Table 5: Global HIV Diagnostics Market Value (US$ Mn), By Test Type, 2015 – 2021

Table 6: Global HIV Diagnostics Market Value (US$ Mn), By Test Type, 2022 – 2032

Table 7: Global HIV Diagnostics Market, By Region, 2015 – 2021

Table 8: Global HIV Diagnostics Market, By Region, 2022 – 2032

Table 9: North America HIV Diagnostics Market Value (US$ Mn), By Product , 2015 – 2021

Table 10: North America HIV Diagnostics Market Value (US$ Mn), By Product , 2022 – 2032

Table 11: North America HIV Diagnostics Market Value (US$ Mn), By End User , 2015 – 2021

Table 12: North America HIV Diagnostics Market Value (US$ Mn), By End User , 2022 – 2032

Table 13: North America HIV Diagnostics Market Value (US$ Mn), By Test Type, 2015 – 2021

Table 14: North America HIV Diagnostics Market Value (US$ Mn), By Test Type, 2022 – 2032

Table 15: North America HIV Diagnostics Market, By Country, 2015 – 2021

Table 16: North America HIV Diagnostics Market, By Country, 2022 – 2032

Table 17: Latin America HIV Diagnostics Market Value (US$ Mn), By Product , 2015 – 2021

Table 18: Latin America HIV Diagnostics Market Value (US$ Mn), By Product , 2022 – 2032

Table 19: Latin America HIV Diagnostics Market Value (US$ Mn), By End User , 2015 – 2021

Table 20: Latin America HIV Diagnostics Market Value (US$ Mn), By End User , 2022 – 2032

Table 21: Latin America HIV Diagnostics Market Value (US$ Mn), By Test Type, 2015 – 2021

Table 22: Latin America HIV Diagnostics Market Value (US$ Mn), By Test Type, 2022 – 2032

Table 23: Latin America HIV Diagnostics Market, By Country, 2015 – 2021

Table 24: Latin America HIV Diagnostics Market, By Country, 2022 – 2032

Table 25: Europe HIV Diagnostics Market Value (US$ Mn), By Product , 2015 – 2021

Table 26: Europe HIV Diagnostics Market Value (US$ Mn), By Product , 2022 – 2032

Table 27: Europe HIV Diagnostics Market Value (US$ Mn), By End User , 2015 – 2021

Table 28: Europe HIV Diagnostics Market Value (US$ Mn), By End User , 2022 – 2032

Table 29: Europe HIV Diagnostics Market Value (US$ Mn), By Test Type, 2015 – 2021

Table 30: Europe HIV Diagnostics Market Value (US$ Mn), By Test Type, 2022 – 2032

Table 31: Europe HIV Diagnostics Market, By Country, 2015 – 2021

Table 32: Europe HIV Diagnostics Market, By Country, 2022 – 2032

Table 33: Asia Pacific HIV Diagnostics Market Value (US$ Mn), By Product , 2015 – 2021

Table 34: Asia Pacific HIV Diagnostics Market Value (US$ Mn), By Product , 2022 – 2032

Table 35: Asia Pacific HIV Diagnostics Market Value (US$ Mn), By End User , 2015 – 2021

Table 36: Asia Pacific HIV Diagnostics Market Value (US$ Mn), By End User , 2022 – 2032

Table 37: Asia Pacific HIV Diagnostics Market Value (US$ Mn), By Test Type, 2015 – 2021

Table 38: Asia Pacific HIV Diagnostics Market Value (US$ Mn), By Test Type, 2022 – 2032

Table 39: Asia Pacific HIV Diagnostics Market, By Country, 2015 – 2021

Table 40: Asia Pacific HIV Diagnostics Market, By Country, 2022 – 2032

Table 41: MEA HIV Diagnostics Market Value (US$ Mn), By Product , 2015 – 2021

Table 42: MEA HIV Diagnostics Market Value (US$ Mn), By Product , 2022 – 2032

Table 43: MEA HIV Diagnostics Market Value (US$ Mn), By End User , 2015 – 2021

Table 44: MEA HIV Diagnostics Market Value (US$ Mn), By End User , 2022 – 2032

Table 45: MEA HIV Diagnostics Market Value (US$ Mn), By Test Type, 2015 – 2021

Table 46: MEA HIV Diagnostics Market Value (US$ Mn), By Test Type, 2022 – 2032

Table 47: MEA HIV Diagnostics Market, By Country, 2015 – 2021

Table 48: MEA HIV Diagnostics Market, By Country, 2022 – 2032

Table 49: Global HIV Diagnostics Market Incremental $ Opportunity, By Product , 2015 - 2021

Table 50: Global HIV Diagnostics Market Incremental $ Opportunity, By End User , 2022 – 2032

Table 51: Global HIV Diagnostics Market Incremental $ Opportunity, By Test Type, 2015 - 2021

Table 52: Global HIV Diagnostics Market Incremental $ Opportunity, By Region, 2022 – 2032

Table 53: North America HIV Diagnostics Market Incremental $ Opportunity, By Product , 2015 - 2021

Table 54: North America HIV Diagnostics Market Incremental $ Opportunity, By End User , 2022 – 2032

Table 55: North America HIV Diagnostics Market Incremental $ Opportunity, By Test Type, 2015 – 2021

Table 56: North America HIV Diagnostics Market Incremental $ Opportunity, By Country, 2022 – 2032

Table 57: Latin America HIV Diagnostics Market Incremental $ Opportunity, By Product , 2015 - 2021

Table 58: Latin America HIV Diagnostics Market Incremental $ Opportunity, By End User , 2022 – 2032

Table 59: Latin America HIV Diagnostics Market Incremental $ Opportunity, By Test Type, 2015 - 2021

Table 60: Latin America HIV Diagnostics Market Incremental $ Opportunity, By Country, 2022 – 2032

Table 61: Europe HIV Diagnostics Market Incremental $ Opportunity, By Product , 2015 - 2021

Table 62: Europe HIV Diagnostics Market Incremental $ Opportunity, By End User , 2022 – 2032

Table 63: Europe HIV Diagnostics Market Incremental $ Opportunity, By Test Type, 2015 - 2021

Table 64: Europe HIV Diagnostics Market Incremental $ Opportunity, By Country, 2022 - 2032

Table 65: Asia Pacific HIV Diagnostics Market Incremental $ Opportunity, By Product , 2015 - 2021

Table 66: Asia Pacific HIV Diagnostics Market Incremental $ Opportunity, By End User , 2022 – 2032

Table 67: Asia Pacific HIV Diagnostics Market Incremental $ Opportunity, By Test Type, 2015 - 2021

Table 68: Asia Pacific HIV Diagnostics Market Incremental $ Opportunity, By Country, 2022 – 2032

Table 69: MEA HIV Diagnostics Market Incremental $ Opportunity, By Product , 2015 - 2021

Table 70: MEA HIV Diagnostics Market Incremental $ Opportunity, By End User , 2022 – 2032

Table 71: MEA HIV Diagnostics Market Incremental $ Opportunity, By Test Type, 2015 - 2021

Table 72: MEA HIV Diagnostics Market Incremental $ Opportunity, By Country, 2022 - 2032

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst
List of Charts

Figure 1: Global HIV Diagnostics Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 2: Global HIV Diagnostics Market Absolute $ Historical Gain (2015 - 2021) and Opportunity (2022 – 2032), US$ Mn

Figure 3: Global HIV Diagnostics Market Share, By Product , 2022 & 2032

Figure 4: Global HIV Diagnostics Market Y-o-Y Growth Projections, By Product – 2022-2032

Figure 5: Global HIV Diagnostics Market Attractiveness Index, By Product – 2022-2032

Figure 6: Global HIV Diagnostics Market Share, By End User , 2022 & 2032

Figure 7: Global HIV Diagnostics Market Y-o-Y Growth Projections, By End User – 2022-2032

Figure 8: Global HIV Diagnostics Market Attractiveness Index, By End User – 2022-2032

Figure 9: Global HIV Diagnostics Market Share, By Test Type, 2022 & 2032

Figure 10: Global HIV Diagnostics Market Y-o-Y Growth Projections, By Test Type – 2022-2032

Figure 11: Global HIV Diagnostics Market Attractiveness Index, By Test Type – 2022-2032

Figure 12: Global HIV Diagnostics Market Share, By Region, 2022 & 2032

Figure 13: Global HIV Diagnostics Market Y-o-Y Growth Projections, By Region – 2022-2032

Figure 14: Global HIV Diagnostics Market Attractiveness Index, By Region – 2022-2032

Figure 15: North America HIV Diagnostics Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 16: North America HIV Diagnostics Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn

Figure 17: North America HIV Diagnostics Market Share, By Product , 2022 & 2032

Figure 18: North America HIV Diagnostics Market Y-o-Y Growth Projections, By Product – 2022-2032

Figure 19: North America HIV Diagnostics Market Attractiveness Index, By Product – 2022-2032

Figure 20: North America HIV Diagnostics Market Share, By End User , 2022 & 2032

Figure 21: North America HIV Diagnostics Market Y-o-Y Growth Projections, By End User – 2022-2032

Figure 22: North America HIV Diagnostics Market Attractiveness Index, By End User – 2022-2032

Figure 23: North America HIV Diagnostics Market Share, By Test Type, 2022 & 2032

Figure 24: North America HIV Diagnostics Market Y-o-Y Growth Projections, By Test Type – 2022-2032

Figure 25: North America HIV Diagnostics Market Attractiveness Index, By Test Type – 2022-2032

Figure 26: North America HIV Diagnostics Market Share, By Country, 2022 & 2032

Figure 27: North America Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 28: North America Market Attractiveness Index, By Country – 2022-2032

Figure 29: Latin America HIV Diagnostics Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 30: Latin America HIV Diagnostics Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn

Figure 31: Latin America HIV Diagnostics Market Share, By Product , 2022 & 2032

Figure 32: Latin America HIV Diagnostics Market Y-o-Y Growth Projections, By Product – 2022-2032

Figure 33: Latin America HIV Diagnostics Market Attractiveness Index, By Product – 2022-2032

Figure 34: Latin America HIV Diagnostics Market Share, By End User , 2022 & 2032

Figure 35: Latin America HIV Diagnostics Market Y-o-Y Growth Projections, By End User – 2022-2032

Figure 36: Latin America HIV Diagnostics Market Attractiveness Index, By End User – 2022-2032

Figure 37: Latin America HIV Diagnostics Market Share, By Test Type, 2022 & 2032

Figure 38: Latin America HIV Diagnostics Market Y-o-Y Growth Projections, By Test Type – 2022-2032

Figure 39: Latin America HIV Diagnostics Market Attractiveness Index, By Test Type – 2022-2032

Figure 40: Latin America HIV Diagnostics Market Share, By Country, 2022 & 2032

Figure 41: Latin America HIV Diagnostics Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 42: Latin America HIV Diagnostics Market Attractiveness Index, By Country – 2022-2032

Figure 43: Europe HIV Diagnostics Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 44: Europe HIV Diagnostics Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn

Figure 45: Europe HIV Diagnostics Market Share, By Product , 2022 & 2032

Figure 46: Europe HIV Diagnostics Market Y-o-Y Growth Projections, By Product – 2022-2032

Figure 47: Europe HIV Diagnostics Market Attractiveness Index, By Product – 2022-2032

Figure 48: Europe HIV Diagnostics Market Share, By End User , 2022 & 2032

Figure 49: Europe HIV Diagnostics Market Y-o-Y Growth Projections, By End User – 2022-2032

Figure 50: Europe HIV Diagnostics Market Attractiveness Index, By End User – 2022-2032

Figure 51: Europe HIV Diagnostics Market Share, By Test Type, 2022 & 2032

Figure 52: Europe HIV Diagnostics Market Y-o-Y Growth Projections, By Test Type – 2022-2032

Figure 53: Europe HIV Diagnostics Market Attractiveness Index, By Test Type – 2022-2032

Figure 54: Europe HIV Diagnostics Market Share, By Country, 2022 & 2032

Figure 55: Europe HIV Diagnostics Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 56: Europe HIV Diagnostics Market Attractiveness Index, By Country – 2022-2032

Figure 57: MEA HIV Diagnostics Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 58: MEA HIV Diagnostics Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn

Figure 59: MEA HIV Diagnostics Market Share, By Product , 2022 & 2032

Figure 60: MEA HIV Diagnostics Market Y-o-Y Growth Projections, By Product – 2022-2032

Figure 61: MEA HIV Diagnostics Market Attractiveness Index, By Product – 2022-2032

Figure 62: MEA HIV Diagnostics Market Share, By End User , 2022 & 2032

Figure 63: MEA HIV Diagnostics Market Y-o-Y Growth Projections, By End User – 2022-2032

Figure 64: MEA HIV Diagnostics Market Attractiveness Index, By End User – 2022-2032

Figure 65: MEA HIV Diagnostics Market Share, By Test Type, 2022 & 2032

Figure 66: MEA HIV Diagnostics Market Y-o-Y Growth Projections, By Test Type – 2022-2032

Figure 67: MEA HIV Diagnostics Market Attractiveness Index, By Test Type – 2022-2032

Figure 68: MEA HIV Diagnostics Market Share, By Country, 2022 & 2032

Figure 69: MEA HIV Diagnostics Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 70: MEA HIV Diagnostics Market Attractiveness Index, By Country – 2022-2032

Figure 71: Asia Pacific HIV Diagnostics Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 72: Asia Pacific HIV Diagnostics Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn

Figure 73: Asia Pacific HIV Diagnostics Market Share, By Product , 2022 & 2032

Figure 74: Asia Pacific HIV Diagnostics Market Y-o-Y Growth Projections, By Product – 2022-2032

Figure 75: Asia Pacific HIV Diagnostics Market Attractiveness Index, By Product – 2022-2032

Figure 76: Asia Pacific HIV Diagnostics Market Share, By End User , 2022 & 2032

Figure 77: Asia Pacific HIV Diagnostics Market Y-o-Y Growth Projections, By End User – 2022-2032

Figure 78: Asia Pacific HIV Diagnostics Market Attractiveness Index, By End User – 2022-2032

Figure 79: Asia Pacific HIV Diagnostics Market Share, By Test Type, 2022 & 2032

Figure 80: Asia Pacific HIV Diagnostics Market Y-o-Y Growth Projections, By Test Type – 2022-2032

Figure 81: Asia Pacific HIV Diagnostics Market Attractiveness Index, By Test Type – 2022-2032

Figure 82: Asia Pacific HIV Diagnostics Market Share, By Country, 2022 & 2032

Figure 83: Asia Pacific HIV Diagnostics Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 84: Asia Pacific HIV Diagnostics Market Attractiveness Index, By Country – 2022-2032

Figure 85: US HIV Diagnostics Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 86: US HIV Diagnostics Market Share, By Product , 2021

Figure 87: US HIV Diagnostics Market Share, By End User , 2021

Figure 88: US HIV Diagnostics Market Share, By Test Type, 2021

Figure 89: Canada HIV Diagnostics Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 90: Canada HIV Diagnostics Market Share, By Product , 2021

Figure 91: Canada HIV Diagnostics Market Share, By End User , 2021

Figure 92: Canada HIV Diagnostics Market Share, By Test Type, 2021

Figure 93: Brazil HIV Diagnostics Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 94: Brazil HIV Diagnostics Market Share, By Product , 2021

Figure 95: Brazil HIV Diagnostics Market Share, By End User , 2021

Figure 96: Brazil HIV Diagnostics Market Share, By Test Type, 2021

Figure 97: Mexico HIV Diagnostics Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 98: Mexico HIV Diagnostics Market Share, By Product , 2021

Figure 99: Mexico HIV Diagnostics Market Share, By End User , 2021

Figure 100: Mexico HIV Diagnostics Market Share, By Test Type, 2021

Figure 101: Germany HIV Diagnostics Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 102: Germany HIV Diagnostics Market Share, By Product , 2021

Figure 103: Germany HIV Diagnostics Market Share, By End User , 2021

Figure 104: Germany HIV Diagnostics Market Share, By Test Type, 2021

Figure 105: U.K. HIV Diagnostics Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 106: U.K. HIV Diagnostics Market Share, By Product , 2021

Figure 107: U.K. HIV Diagnostics Market Share, By End User , 2021

Figure 108: U.K. HIV Diagnostics Market Share, By Test Type, 2021

Figure 109: France HIV Diagnostics Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 110: France HIV Diagnostics Market Share, By Product , 2021

Figure 111: France HIV Diagnostics Market Share, By End User , 2021

Figure 112: France HIV Diagnostics Market Share, By Test Type, 2021

Figure 113: Italy HIV Diagnostics Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 114: Italy HIV Diagnostics Market Share, By Product , 2021

Figure 115: Italy HIV Diagnostics Market Share, By End User , 2021

Figure 116: Italy HIV Diagnostics Market Share, By Test Type, 2021

Figure 117: BENELUX HIV Diagnostics Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 118: BENELUX HIV Diagnostics Market Share, By Product , 2021

Figure 119: BENELUX HIV Diagnostics Market Share, By End User , 2021

Figure 120: BENELUX HIV Diagnostics Market Share, By Test Type, 2021

Figure 121: Nordic Countries HIV Diagnostics Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 122: Nordic Countries HIV Diagnostics Market Share, By Product , 2021

Figure 123: Nordic Countries HIV Diagnostics Market Share, By End User , 2021

Figure 124: Nordic Countries HIV Diagnostics Market Share, By Test Type, 2021

Figure 125: China HIV Diagnostics Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 126: China HIV Diagnostics Market Share, By Product , 2021

Figure 127: China HIV Diagnostics Market Share, By End User , 2021

Figure 128: China HIV Diagnostics Market Share, By Test Type, 2021

Figure 129: Japan HIV Diagnostics Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 130: Japan HIV Diagnostics Market Share, By Product , 2021

Figure 131: Japan HIV Diagnostics Market Share, By End User , 2021

Figure 132: Japan HIV Diagnostics Market Share, By Test Type, 2021

Figure 133: South Korea HIV Diagnostics Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 134: South Korea HIV Diagnostics Market Share, By Product , 2021

Figure 135: South Korea HIV Diagnostics Market Share, By End User , 2021

Figure 136: South Korea HIV Diagnostics Market Share, By Test Type, 2021

Figure 137: GCC Countries HIV Diagnostics Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 138: GCC Countries HIV Diagnostics Market Share, By Product , 2021

Figure 139: GCC Countries HIV Diagnostics Market Share, By End User , 2021

Figure 140: GCC Countries HIV Diagnostics Market Share, By Test Type, 2021

Figure 141: South Africa HIV Diagnostics Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 142: South Africa HIV Diagnostics Market Share, By Product , 2021

Figure 143: South Africa HIV Diagnostics Market Share, By End User , 2021

Figure 144: South Africa HIV Diagnostics Market Share, By Test Type, 2021

Figure 145: Turkey HIV Diagnostics Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 146: Turkey HIV Diagnostics Market Share, By Product , 2021

Figure 147: Turkey HIV Diagnostics Market Share, By End User , 2021

Figure 148: Turkey HIV Diagnostics Market Share, By Test Type, 2021

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Poultry Diagnostics Market

Published : November 2020

Healthcare

Companion Diagnostics Market

Published : February 2016

Healthcare

Infectious Disease Diagnostics Market

Published : January 2016

Healthcare

Cancer Diagnostics Market

Published : March 2021

Google translate

HIV Diagnostics Market